All LGP products are manufactured at a TGA GMP-certified manufacturing facility in accordance with Good Manufacturing Practices (GMP) requirements.
LGP medicinal cannabis oils are manufactured from a whole plant (full spectrum) extract together with medium-chain triglyceride (MCT) oil. LGP medical cannabis preparations provide various THC and CBD profiles:
THC is frequently associated with treatment of chronic pain, inflammation, spasticity, and nausea, while CBD is a non-psychoactive cannabinoid that is typically used for seizure, pain, inflammation and anxiety. They are commonly both found in the medicinal cannabis products as they may work synergistically, and CBD is believed to antagonise the adverse effects of THC.
LGP has formulations with different THC and CBD ratios which may provide different therapeutic effects, interact differently in each patient’s endocannabinoid system, and impose different adverse effects in patients.